die(' Site is under construction

Dear site users

Site is under construction.

The site will be ready in less than 24 hours.

We are sorry for the inconvenience.

www.yektaweb.com

'); Reports of Biochemistry and Molecular Biology rbmb.net Basic Sciences http://rbmb.net 1 admin 2322-3480 2322-3480 10.61882/rbmb en jalali 1398 10 1 gregorian 2020 1 1 8 4 online 1 fulltext
en Identification of Novel Pathogenic PKD2 Variants in Iranian Patients with Autosomal Dominant Polycystic Kidney Disease زیست شناسی ملکولی Molecular Biology مقالات اصلی Original Article <div style="text-align: justify;"><strong><em>Background:</em></strong> Autosomal dominant polycystic kidney disease (ADPKD) is a delayed-onset renal disorder that results from a mutation in the <em>PKD1</em> or <em>PKD2</em> genes. Autosomal dominant polycystic kidney disease results in end-stage renal disease due to renal cystic dysplasia. The aim of this study was to evaluate, by exon sequencing, the disease-causing variants of <em>PKD2</em> (exons 4, 6, and 8) in Iranian ADPKD patients.<br> <br> <strong><em>Methods:</em></strong> Genomic DNA was extracted from 3-5 ml of peripheral blood by the salting-out method. <em>PKD2</em> exons 4, 6, and 8 were PCR-amplified and sequenced.<br> <br> <strong><em>Results:</em></strong> Three disease-causing <em>PKD2</em> variants were identified; all three were missense mutations in exon 4. The mutations were AGC &rarr; ACC (c.893G>C, cDNA.959G>C, S298T), TAC &rarr; TTC (c.1043A>T, cDNA.1109 A>T, Y348F), and GAA &rarr; GAT (c.1059A>T, cDNA.1125 A>T, E353D. These novel pathogenic variants may cause loss of the normal protein function.<br> <br> <strong><em>Conclusions:</em></strong> Our results suggest that AGC &rarr; ACC (c.893G>C, cDNA.959G>C, S298T), TAC &rarr; TTC (c.1043A>T, cDNA.1109 A>T, Y348F), and GAA &rarr; GAT (c.1059A>T, cDNA.1125 A>T, E353D variants are common in Iranian ADPKD patients. These mutations modify the transmembrane domain and likely influence PC2 function.</div> Pathogenic Variants, PKD2, Autosomal Dominant Polycystic Kidney Disease. 401 406 http://rbmb.net/browse.php?a_code=A-10-233-2&slc_lang=en&sid=1 Morteza Bagheri mortazabagheri@yahoo.com 100319475328460017424 100319475328460017424 Yes Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran. & Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. Khadijeh Makhdoomi makhdoomikhadijeh@yahoo.com 100319475328460017425 100319475328460017425 No Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran. Ali Taghizadeh Afshari atafshari@yahoo.com 100319475328460017426 100319475328460017426 No Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran. Ahmad Ali Nikibakhsh anikibakhsh@yahoo.com 100319475328460017427 100319475328460017427 No Nephrology and Kidney Transplant Research Center, Urmia University of Medical Sciences, Urmia, Iran. Isa Abdi Rad isaabdirad@yahoo.com 100319475328460017428 100319475328460017428 No Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.